Future directions in acute liver failure
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Acute liver failure (ALF) describes a clinical syndrome of rapid hepatocyte injury leading to liver failure manifested by coagulopathy and encephalopathy in the absence of pre-existing cirrhosis. The hallmark diagnostic features are a prolonged prothrombin time (ie, an international normalized ratio of prothrombin time of ≥1.5) and any degree of mental status alteration (HE). As a rare, orphan disease, it seemed an obvious target for a multicenter network. The Acute Liver Failure Study Group (ALFSG) began in 1997 to more thoroughly study and understand the causes, natural history, and management of ALF. Over the course of 22 years, 3364 adult patients were enrolled in the study registry (2614 ALF and 857 acute liver injury—international normalized ratio 2.0 but no encephalopathy—ALI) and >150,000 biosamples collected, including serum, plasma, urine, DNA, and liver tissue. Within the Registry study sites, 4 prospective substudies were conducted and published, 2 interventional (N-acetylcysteine and ornithine phenylacetate), 1 prognostic [13 C-methacetin breath test (MBT)], and 1 mechanistic (rotational thromboelastometry). To review ALFSG’s accomplishments and consider next steps, a 2-day in-person conference was held at UT Southwestern Medical Center, Dallas, TX, entitled “Acute Liver Failure: Science and Practice,” in May 2022. To summarize the important findings in the field, this review highlights the current state of understanding of ALF and, more importantly, asks what further studies are needed to improve our understanding of the pathogenesis, natural history, and management of this unique and dramatic condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Liver regeneration: biological and pathological mechanisms and implications
Michalopoulos, G. K., & Bhushan, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0342-4 · Cited by 998 · cited 2×
“[59,60] Most studies on liver regeneration rely on DILI models involving systemic exposure to hepatotoxicants such as carbon tetrachloride, thioacetamide, or APAP.”
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Self-citationYang, W., Tao, Y., Wu, Y., Zhao, X., Ye, W., Zhao, D., Fu, L., Tian, C., Yang, J., He, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09046-8 · Cited by 367 · cited 2×
“[56,57] Collectively, these studies have identified an intricate Molecular mechanisms of non-APAP liver injury.”
Mossanen, J. C., Krenkel, O., Ergen, C., Govaere, O., Liepelt, A., Puengel, T., Heymann, F., Kalthoff, S., Lefebvre, E., Eulberg, D., et al. (2016) · Hepatology · doi:10.1002/hep.28682 · Cited by 325
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307 · cited 1×
“[58] Many studies have shown that a compensatory regenerative response is stimulated following liver injury that plays a decisive role in the final outcome.”
Measurement of Serum Acetaminophen–Protein Adducts in Patients With Acute Liver Failure
Davern, T. J., James, L. P., Hinson, J. A., Polson, J., Larson, A. M., Fontana, R. J., Lalani, E., Munoz, S., Shakil, A. O., & Lee, W. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.033 · Cited by 284
Self-citationIn Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity
Zhang, K., Zhang, L., Liu, W., Ma, X., Cen, J., Sun, Z., Wang, C., Feng, S., Zhang, Z., Yue, L., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.018 · Cited by 252 · cited 1×
“This is likely to be achieved by expansion and differentiation of stem cells either in vitro [155,156] or in vivo .”
Research works printed but not linked: 143
- Trey, 1970, The management of fulminant hepatic failure, Prog Liver Dis, 3, 282
- Lee, 2008, Acute liver failure: summary of a workshop, Hepatology, 47, 1401, 10.1002/hep.22177 · DOI · Paper page
- Stravitz, 2019, Seminar: Acute liver failure, Lancet, 394, 869, 10.1016/S0140-6736(19)31894-X · DOI · Paper page
- Bernal, 2015, Acute liver failure: a curable disease by 2024?, J Hepatol, 62, S112, 10.1016/j.jhep.2014.12.016 · DOI · Paper page
- Kamimura, 2023, Analysis of drug-induced liver-related adverse event trend reporting between 1997 and 2019, Hepatol Res, 53, 556, 10.1111/hepr.13883 · DOI · Paper page
- Lee, 2017, Public health: acetaminophen (APAP) hepatotoxicity—isn’t it time for APAP to go away?, J Hepatol, 67, 1324, 10.1016/j.jhep.2017.07.005 · DOI · Paper page
- Reuben, 2016, Outcomes in adults with acute liver failure (ALF) from 1998-2013: An observational cohort study, Ann Intern Med, 164, 724, 10.7326/M15-2211 · DOI · Paper page
- Wendon, 2017, EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure, J Hepatol, 66, 1047, 10.1016/j.jhep.2016.12.003 · DOI · Paper page
- O'Grady, 1993, Acute liver failure: redefining the syndromes, Lancet, 342, 273, 10.1016/0140-6736(93)91736-6 · DOI · Paper page
- Reddy, 2016, Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States, Liver Transpl, 22, 505, 10.1002/lt.24347 · DOI · Paper page
- Murphy, 2016, Progress toward eliminating hepatitis A disease in the United States, MMWR Suppl, 65, 29, 10.15585/mmwr.su6501a6 · DOI · Paper page
- Somasekar, 2017, Viral surveillance in serum samples from patients with acute liver failure by metagenomic next-generation sequencing, Clin Infect Dis, 65, 1477, 10.1093/cid/cix596 · DOI · Paper page
- Ganger, 2018, Acute liver failure of indeterminate etiology: A comprehensive systematic approach by an expert committee to establish causality, Am J Gastroenterol, 113, 1319, 10.1038/s41395-018-0160-2 · DOI · Paper page
- Stravitz, 2011, Autoimmune acute liver failure: proposed clinical and histological criteria, Hepatology, 53, 517, 10.1002/hep.24080 · DOI · Paper page
- Enke, 2023, Autoimmune hepatitis presenting as acute liver failure. A 20-year retrospective review of North America, Liver Transpl, 29, 570, 10.1097/LVT.0000000000000105 · DOI
- Rockey, 2010, Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method, Hepatology, 51, 2117, 10.1002/hep.23577 · DOI · Paper page
- Rao, 2022, Secular trends in severe idiosyncratic drug-induced liver injury in North America: An update from the Acute Liver Failure Study Group Registry, Am J Gastroenterol, 117, 617, 10.14309/ajg.0000000000001655 · DOI · Paper page
- Squires, 2006, Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group, J Pediatr, 148, 652, 10.1016/j.jpeds.2005.12.051 · DOI · Paper page
- Zellos, 2022, Proceedings of ESPGHAN Monothematic Conference 2020: Acute liver failure in children: Diagnosis and initial management, J Pediatr Gastroenterol Nutr, 74, e45
- Squires, 2022, North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure, J Pediatr Gastroenterol Nutr, 74, 138, 10.1097/MPG.0000000000003268 · DOI
- Di Giorgio, 2021, Diagnostic approach to acute liver failure in children: A position paper by the SIGENP liver disease working group, Dig Liv Dis, 53, 545, 10.1016/j.dld.2021.03.004 · DOI
- Narkewicz, 2018, A learning collaborative approach increases specificity of diagnosis of acute liver failure in pediatric patients, Clin Gastroenterol Hepatol, 16, 1801, 10.1016/j.cgh.2018.04.050 · DOI
- Li, 2016, Clinical course among cases of acute liver failure of indeterminate diagnosis, J Pediatr, 171, 163, 10.1016/j.jpeds.2015.12.065 · DOI
- Chapin, 2018, Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate, Hepatology, 68, 1087, 10.1002/hep.29901 · DOI
- Kulkarni, 2022, An update on pediatric acute liver failure: emerging understanding of the impact of immune dysregulation and novel opportunities for intervention, Clin Liver Dis, 26, 461, 10.1016/j.cld.2022.03.007 · doi:10.1016/j.cld.2022.03.007
- Lee, 2009, Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure, Gastroenterology, 137, 856, 10.1053/j.gastro.2009.06.006 · DOI · Paper page
- Sanabria-Cabrera, 2022, N-Acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults: A systematic review, Front Pharmacol, 13, 876868, 10.3389/fphar.2022.876868 · DOI · Paper page
- Squires, 2013, Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial, Hepatology, 57, 1542, 10.1002/hep.26001 · DOI · Paper page
- Kelgeri, 2022, Clinical spectrum of children with acute hepatitis of unknown cause, N Engl J Med, 387, 611, 10.1056/NEJMoa2206704 · doi:10.1056/nejmoa2206704
- Pan, 2022, CAQ Corner: Acute liver failure management and liver transplantation, Liver Transpl, 28, 1664, 10.1002/lt.26503 · DOI · Paper page
- Squires, 2018, Liver transplant listing in pediatric acute liver failure: practices and participant characteristics, Hepatology, 68, 2338, 10.1002/hep.30116 · DOI
- Lefkowitch, 2016, The pathology of acute liver failure, Adv Anat Pathol, 23, 144, 10.1097/PAP.0000000000000112 · DOI
- Lisman, 2018, Platelets as modulators of liver diseases, Semin Thromb Hemost, 44, 114, 10.1055/s-0037-1604091 · DOI · Paper page
- Kleiner, 1997, Histopathologic changes associated with fialuridine hepatotoxicity, Mod Pathol, 10, 192
- Portmann, 1975, Histopathological changes in the liver following paracetamol overdose: correlation with clinical and biochemical parameters, J Pathol, 117, 169, 10.1002/path.1711170307 · DOI · Paper page
- Kleiner, 2009, The pathology of drug-induced liver injury, Semin Liver Dis, 29, 364, 10.1055/s-0029-1240005 · DOI · Paper page
- Shojaie, 2020, Cell death in liver diseases: a review, Int J Mol Sci, 21, 9682, 10.3390/ijms21249682 · DOI · Paper page
- Dara, 2015, Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis, Hepatology, 62, 1847, 10.1002/hep.27939 · DOI · Paper page
- Rutherford, 2012, Development of an accurate index for predicting outcomes of patients with acute liver failure, Gastroenterology, 143, 1237, 10.1053/j.gastro.2012.07.113 · DOI · Paper page
- Singanayagam, 2021, Macrophages in chronic liver failure: dDiversity, plasticity and therapeutic targeting, Front Immunol, 12, 661182, 10.3389/fimmu.2021.661182 · DOI
- Triantafyllou, 2018, The role of monocytes and macrophages in acute and acute-on-chronic liver failure, Front Immunol, 9, 2948, 10.3389/fimmu.2018.02948 · DOI · Paper page
- Antoniades, 2014, Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure, Hepatology, 59, 1564, 10.1002/hep.26933 · DOI · Paper page
- Triantafyllou, 2021, PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury, J Clin Invest, 131, e140196, 10.1172/JCI140196 · DOI · Paper page
- Slaba, 2015, Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice, Hepatology, 62, 1593, 10.1002/hep.28003 · DOI · Paper page
- Chauhan, 2020, The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure, Nat Commun, 11, 1939, 10.1038/s41467-020-15584-3 · DOI · Paper page
- Mehendale, 2005, Tissue repair: an important determinant of final outcome of toxicant-induced injury, Toxicol Pathol, 33, 41, 10.1080/01926230590881808 · DOI · Paper page
- Ramachandran, 2019, Acetaminophen hepatotoxicity, Semin Liver Dis, 39, 221, 10.1055/s-0039-1679919 · DOI · Paper page
- Little, 2019, Herpes simplex virus-associated acute liver failure often goes unrecognized, Hepatology, 69, 917, 10.1002/hep.30236 · DOI
- Ajmera, 2011, What factors determine the severity of hepatitis A related acute liver failure?, J Viral Hep, 18, e174, 10.1111/j.1365-2893.2010.01410.x · DOI
- Jouanguy, 2020, Human genetic basis of fulminant viral hepatitis, Human Genetics, 139, 877, 10.1007/s00439-020-02166-y · DOI
- Belkaya, 2019, Inherited IL-18BP deficiency in human fulminant viral hepatitis, J Exp Med, 216, 1777, 10.1084/jem.20190669 · DOI
- Hinson, 1995, Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts, Drug Metabol Rev, 27, 73, 10.3109/03602539509029816 · DOI
- Khandelwal, 2011, Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure, Hepatology, 53, 567, 10.1002/hep.24060 · DOI · Paper page
- Muldrew, 2002, Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection, Drug Metab Dispos, 30, 446, 10.1124/dmd.30.4.446 · DOI · Paper page
- Roberts, 2017, An immunoassay to rapidly measure acetaminophen protein adducts accurately identifies patients with acute liver injury or failure, Clin Gastroenterol Hepatol, 15, 555, 10.1016/j.cgh.2016.09.007 · DOI · Paper page
- Rabinowich, 2016, Clinical management of acute liver failure: results of an international multi-center survey, World J Gastroenterol, 22, 7595, 10.3748/wjg.v22.i33.7595 · DOI · Paper page
- Bernal, 2013, Lessons from look-back in acute liver failure ? A single centre experience of 3300 patients, J Hepatol, 59, 74, 10.1016/j.jhep.2013.02.010 · DOI · Paper page
- MacDonald, 2021, Clinical and neurologic outcomes in acetaminophen induced acute liver failure: A 21-year multicenter cohort study, Clin Gastroenterol Hepatol, 19, 2615, 10.1016/j.cgh.2020.09.016 · DOI · Paper page
- Bernal, 2002, Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study, Lancet, 359, 558, 10.1016/S0140-6736(02)07743-7 · DOI · Paper page
- Bernal, 2016, Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study, Lancet Gastroenterol Hepatol, 1, 217, 10.1016/S2468-1253(16)30007-3 · DOI
- Bismuth, 1995, Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience, Ann Surg, 222, 109, 10.1097/00000658-199508000-00002 · DOI · Paper page
- McPhail, 2010, Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure, J Hepatol, 53, 492, 10.1016/j.jhep.2010.03.023 · DOI
- Cholongitas, 2012, Comparison of the sequential organ failure assessment score with the King’s College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure, Liver Transpl, 18, 405, 10.1002/lt.23370 · DOI · Paper page
- Koch, 2016, Development of a model to predict transplant-free survival of patients with acute liver failure, Clin Gastroenterol Hepatol, 14, 1199, 10.1016/j.cgh.2016.03.046 · DOI · Paper page
- Everson, 2012, Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial, Hepatology, 55, 1019, 10.1002/hep.24752 · DOI
- Fontana, 2021, Prognostic value of the 13C-methacetin breath test in adults with acute liver failure and non-acetaminophen acute liver injury, Hepatology, 74, 961, 10.1002/hep.31783 · DOI
- Rakela, 2023, Acute liver failure: biomarkers evaluated by the acute liver failure study group, Clin Translat Gastroenterol, 14, e00565, 10.14309/ctg.0000000000000565 · DOI
- Schiodt, 2006, Alpha-fetoprotein and prognosis in acute liver failure, Liver Transpl, 12, 1776, 10.1002/lt.20886 · DOI · Paper page
- Rutherford, 2007, Serum apoptosis markers in acute liver failure: A pilot study, Clin Gastroenterol Hepatol, 5, 1477, 10.1016/j.cgh.2007.08.007 · DOI
- Schiodt, 2007, Predictive value of actin-free Gc-globulin in acute liver failure, Liver Transpl, 13, 1324, 10.1002/lt.21236 · DOI
- Woolbright, 2014, Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients, Toxicol Sci, 142, 436, 10.1093/toxsci/kfu195 · DOI · Paper page
- Basta, 2015, Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure, Liver Transpl, 21, 847, 10.1002/lt.24129 · DOI
- Srungaram, 2015, Plasma osteopontin in acute liver failure, Cytokine, 73, 270, 10.1016/j.cyto.2015.02.021 · DOI · Paper page
- Laursen, 2015, Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure, Liver Int, 35, 756, 10.1111/liv.12682 · DOI
- Rosen, 2016, Association between plasma level of galectin-9 and survival of patients with drug-induced acute liver failure, Clin Gastroenterol Hepatol, 14, 606, 10.1016/j.cgh.2015.09.040 · DOI
- Karvellas, 2017, Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure, Hepatology, 69, 938, 10.1002/hep.28945 · DOI · Paper page
- Karvellas, 2021, Elevated serum liver-type fatty acid binding protein levels in non-acetaminophen acute liver failure patients with organ dysfunction, Dig Dis Sci, 66, 273, 10.1007/s10620-020-06166-w · DOI
- Slowik, 2019, Leukocyte cell derived chemotaxin-2 (Lect2) as a predictor of survival in adult acute liver failure, Transl Gastroenterol Hepatol, 4, 17, 10.21037/tgh.2019.03.03 · DOI
- Tavabie, 2021, A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure, J Hepatol, 75, 424, 10.1016/j.jhep.2021.03.013 · DOI
- Patidar, 2021, Admission Factor V predicts transplant-free survival in acute liver failure, Dig Dis Sci, 66, 619, 10.1007/s10620-020-06197-3 · DOI
- Stravitz, 2016, Thrombocytopenia is associated with multi-organ system failure in patients with acute liver failure, Clin Gastroenterol Hepatol, 14, 613, 10.1016/j.cgh.2015.09.029 · DOI · Paper page
- Glavind, 2020, The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease, Orphanet J Rare Dis, 15, 173, 10.1186/s13023-020-01452-2 · DOI
- Strnad, 2010, Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations, Gastroenterology, 139, 828, 10.1053/j.gastro.2010.06.007 · DOI · Paper page
- Court, 2013, The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C > G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure, J Pharmacol Exp Ther, 345, 297, 10.1124/jpet.112.202010 · DOI
- Randesi, 2017, Association of variants of arginine vasopressin and arginine vasopressin receptor 1A with severe acetaminophen liver injury, Cell Mol Gastroenterol Hepatol, 3, 500, 10.1016/j.jcmgh.2017.01.008 · DOI
- Ajmera, 2019, Host genetic variant in CXCL16 may be associated with hepatitis B virus-related acute liver failure, Cell Mol Gastroenterol Hepatol, 7, 477, 10.1016/j.jcmgh.2018.09.018 · DOI
- Dao, 2012, Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure, Dig Dis Sci, 57, 1349, 10.1007/s10620-011-2013-3 · DOI · Paper page
- Butterworth, 2015, Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure, J Clin Exp Hepatol, 5, S96, 10.1016/j.jceh.2014.02.004 · DOI
- Bernal, 2007, Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure, Hepatology, 46, 1844, 10.1002/hep.21838 · DOI · Paper page
- Stravitz, 2018, Safety, tolerability and pharmacokinetics of L-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia, Hepatology, 67, 1003, 10.1002/hep.29621 · DOI
- Vaquero, 2005, Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy, Liver Transpl, 11, 1581, 10.1002/lt.20625 · DOI · Paper page
- Karvellas, 2014, Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study, Crit Care Med, 42, 1157, 10.1097/CCM.0000000000000144 · DOI · Paper page
- Stravitz, 2018, Bleeding complications in acute liver failure, Hepatology, 67, 1931, 10.1002/hep.29694 · DOI · Paper page
- Rajajee, 2011, Optic nerve ultrasound for the detection of raised intracranial pressure, Neurocrit Care, 15, 506, 10.1007/s12028-011-9606-8 · doi:10.1007/s12028-011-9606-8
- Rajajee, 2018, Noninvasive intracranial pressure assessment in acute liver failure, Neurocrit Care, 29, 280, 10.1007/s12028-018-0540-x · DOI
- Kawakami, 2010, Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure, Clin Imaging, 34, 327, 10.1016/j.clinimag.2009.09.006 · doi:10.1016/j.clinimag.2009.09.006
- Murphy, 2004, The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure, Hepatology, 39, 464, 10.1002/hep.20056 · DOI · Paper page
- Cardoso, 2018, Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure, Hepatology, 67, 711, 10.1002/hep.29488 · DOI · Paper page
- Bernal, 2016, A multicentre randomized controlled trial of moderate hypothermia to prevent intracranial hypertension in acute liver failure, J Hepatol, 65, 273, 10.1016/j.jhep.2016.03.003 · DOI
- Nanchal, 2020, Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: Cardiovascular, endocrine, hematologic, pulmonary, and renal considerations, Crit Care Med, 48, e173, 10.1097/CCM.0000000000004192 · DOI · Paper page
- Canalese, 1982, Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure, Gut, 23, 625, 10.1136/gut.23.7.625 · DOI · Paper page
- Jalan, 2004, Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension, Gastroenterology, 127, 1338, 10.1053/j.gastro.2004.08.005 · DOI · Paper page
- Forbes, 1989, Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure, Hepatology, 10, 306, 10.1002/hep.1840100309 · DOI · Paper page
- Muñoz, 1991, Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure, Hepatology, 13, 209, 10.1002/hep.1840130202 · DOI
- Kalal, 2022, Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial, Dig Dis, 40, 607, 10.1159/000520229 · DOI
- Vaquero, 2007, Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity, Gastroenterology, 132, 372, 10.1053/j.gastro.2006.11.025 · DOI
- Karvellas, 2015, Therapeutic hypothermia in acute liver failure: A multicenter retrospective cohort analysis, Liver Transpl, 21, 4, 10.1002/lt.24021 · DOI
- Fernando, 2021, Targeted temperature management following out-of-hospital cardiac arrest: A systematic review and network meta-analysis of temperature targets, Intensive Care Med, 47, 1078, 10.1007/s00134-021-06505-z · DOI
- Dong, 2020, Significant lung injury and its prognostic significance in acute liver failure: A cohort analysis, Liver Int, 40, 654, 10.1111/liv.14268 · DOI
- Antoniades, 2008, The importance of immune dysfunction in determining outcome in acute liver failure, J Hepatol, 49, 845, 10.1016/j.jhep.2008.08.009 · DOI · Paper page
- Taylor, 2013, Circulating neutrophil dysfunction in acute liver failure, Hepatology, 57, 1142, 10.1002/hep.26102 · DOI · Paper page
- Rolando, 1996, Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure, Liver Transpl Surg, 2, 8, 10.1002/lt.500020103 · DOI
- Karvellas, 2014, Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: A retrospective cohort study, Clin Gastroenterol Hepatol, 12, 1942, 10.1016/j.cgh.2014.03.011 · DOI · Paper page
- Vaquero, 2003, Infection and the progression of hepatic encephalopathy in acute liver failure, Gastroenterology, 125, 755, 10.1016/S0016-5085(03)01051-5 · DOI · Paper page
- Rolando, 1991, Fungal infection: A common, unrecognised complication of acute liver failure, J Hepatol, 12, 1, 10.1016/0168-8278(91)90900-V · DOI · Paper page
- Rolando, 2000, The systemic inflammatory response syndrome in acute liver failure, Hepatology, 32, 734, 10.1053/jhep.2000.17687 · DOI · Paper page
- Harry, 2002, The clinical importance of adrenal insufficiency in acute hepatic dysfunction, Hepatology, 36, 395, 10.1053/jhep.2002.34514 · DOI · Paper page
- Larsen, 2016, High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial, J Hepatol, 64, 69, 10.1016/j.jhep.2015.08.018 · DOI · Paper page
- Driever, 2021, VWF/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure, Hepatology, 73, 1882, 10.1002/hep.31507 · DOI
- Stravitz, 2013, Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure, Hepatology, 58, 304, 10.1002/hep.26307 · DOI · Paper page
- Stravitz, 2012, Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography, J Hepatol, 56, 129, 10.1016/j.jhep.2011.04.020 · DOI · Paper page
- Lisman, 2012, Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure, J Thromb Haemost, 10, 1312, 10.1111/j.1538-7836.2012.04770.x · DOI
- Lisman, 2015, Rebalanced hemostasis in patients with acute liver failure, Semin Thromb Hemost, 41, 468, 10.1055/s-0035-1550430 · DOI · Paper page
- Pereira, 2005, Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease, J Hepatol, 42, 365, 10.1016/j.jhep.2004.11.030 · doi:10.1016/j.jhep.2004.11.030
- Leithead, 2009, The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure, Gut, 58, 443, 10.1136/gut.2008.154120 · DOI · Paper page
- Warrillow, 2020, Correction and control of hyperammonemia in acute liver failure: The impact of continuous renal replacement timing, intensity, and duration, Crit Care Med, 48, 218, 10.1097/CCM.0000000000004153 · DOI
- Fisher, 2022, Ammonia clearance with different continuous renal replacement therapy techniques in patients with liver failure, Blood Purif, 51, 840, 10.1159/000521312 · DOI
- Slack, 2014, Ammonia clearance with haemofiltration in adults with liver disease, Liver Int, 34, 42, 10.1111/liv.12221 · DOI · Paper page
- Hamdi, 2018, High sodium continuous veno-venous hemodialysis with regional citrate anticoagulation and online dialysate generation in patients with acute liver failure and cerebral edema, Hemodial Int, 22, 184, 10.1111/hdi.12572 · DOI
- Saliba, 2022, Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts, Int Care Med, 48, 1352
- Tandon, 2021, Artificial liver support systems, J Gastro & Hepatol, 36, 1164, 10.1111/jgh.15255 · DOI
- MacDonald, 2022, Use of the molecular adsorbent recirculating system in acute liver failure: results of a multicenter propensity score-matched study, Crit Care Med, 50, 286, 10.1097/CCM.0000000000005194 · DOI
- Saliba, 2013, Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial, Ann Intern Med, 159, 522, 10.7326/0003-4819-159-8-201310150-00005 · DOI · Paper page
- Glorioso, 2015, Pivotal preclinical trial of the spheroid reservoir bioartificial liver, J Hepatology, 63, 388, 10.1016/j.jhep.2015.03.021 · DOI · Paper page
- Huang, 2014, Direct reprogramming of human fibroblasts to functional and expandable hepatocytes, Cell Stem Cell, 14, 370, 10.1016/j.stem.2014.01.003 · DOI · Paper page
- Zhou, 2019, Stem cell-related studies and stem cell-based therapies in liver diseases, Cell Transplant, 28, 1116, 10.1177/0963689719859262 · DOI
- Yao, 2022, Induced pluripotent stem cells for the treatment of liver diseases: Novel concepts, Cells, Tissues and Organs, 211, 368
- Wu, 2017, Interspecies chimerism with mammalian pluripotent stem cells, Cell, 168, 473, 10.1016/j.cell.2016.12.036 · DOI · Paper page
- Larson, 2021, Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production, Stem Cell Reports, 16, 2577, 10.1016/j.stemcr.2021.09.018 · DOI
- Karvellas, 2010, Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: A case-control study, Liver Int, 30, 826, 10.1111/j.1478-3231.2010.02243.x · DOI
- Pezzia, 2017, Psychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury, J Psychosom Res, 101, 51, 10.1016/j.jpsychores.2017.08.006 · DOI
- Germani, 2012, Liver transplantation for acute liver failure in Europe: Outcomes over 20 years from the ELTR database, J Hepatol, 57, 288, 10.1016/j.jhep.2012.03.017 · DOI · Paper page
- Karvellas, 2022, Outcomes of acute liver failure patients listed for liver transplantation: A multicenter prospective cohort analysis, Liver Transpl
Cited by
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Deng, B., Ma, Y., Huang, J., He, R., Luo, M., Mao, L., Zhang, E., Zhao, Y., Wang, X., Wang, Q., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado1550 · Cited by 47
Bioinspired Spatially Ordered Multicellular Lobules for Liver Regeneration
Wang, J., Huang, D., Ren, H., & Zhao, Y. (2025) · Research · doi:10.34133/research.0634 · Cited by 10
Metadata
- Authors
- Stravitz, R. T., Fontana, R. J., Karvellas, C., Durkalski, V., McGuire, B., Rule, J. A., Tujios, S., Lee, W. M., & for the Acute Liver Failure Study Group
- Venue
- Hepatology
- Published
- 2023-05-16
- Volume
- 78
- Issue
- 4
- Pages
- 1266-1289
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4376616796
- Cited by
- 132
- References
- 21
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Future directions in acute liver failure. https://app.cochat.ai/papers/10.1097/hep.0000000000000458
- The paper
- Stravitz, R. T., Fontana, R. J., Karvellas, C., Durkalski, V., McGuire, B., Rule, J. A., Tujios, S., Lee, W. M., & for the Acute Liver Failure Study Group. (2023). Future directions in acute liver failure. Hepatology. https://doi.org/10.1097/hep.0000000000000458
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.